2m 2m 2m 2m 2m 2m 2m
GENPREX (GNPX)
NASDAQ
$3.40+$0.05 (+1.40%)
Price as of Sep 11, 2026 7:55 PM EDT- $2.7MMarket Cap
- -98.96%1-Year Change
- BiotechnologyIndustry
GENPREX (GNPX)
$3.40+$0.05 (+1.40%)
GNPX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.35 | ||
Change | $0.00 (0.00%) | ||
Open | $3.39 | ||
High | $3.43 | ||
Low | $3.33 | ||
Previous Close | $3.35 | ||
Volume | 28,159 | ||
30-Day Average Volume | 278,061 | ||
1-Week Change | -4.29% | ||
1-Month Change | -25.06% | ||
1-Year Change | -98.96% | ||
3-Year Change | -99.99% | ||
5-Year Change | -100.00% | ||
Fundamentals | |||
Shares Outstanding | 819,709 | ||
Total Assets | $17.1M | ||
Market Cap | $2.7M | ||
Enterprise Value | -$12.4M | ||
Period: QTR TTM FY | |||
Revenue | $541.00 | ||
Net Income | -$4.5M | ||
Free Cash Flow | -$3.1M | ||
EBIT | -$4.5M | ||
EBITDA | -$4.5M | ||
Net Working Capital | $15.4M | ||
EPS | -$14.08 | ||
Enterprise Value/EBITDA | 3 | ||
Enterprise Value/Revenue | -28,287 | ||
P/B | 0 | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 22 | ||
Last Split Date | 07/16/2026 | ||
Earnings & Revenue